US5091389A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Lipophilic macrolide useful as an immunosuppressant
Assignee: Merck and Co Inc
•
Filing: 1991-04-23
•
Granted: 1992-02-25
•
Expires: 2011-04-23
Abstract
Abstract Disclosed is a novel lipophilic macrolide of assigned Formula I: ##STR1## The compound of assigned Formula I is an analog of rapamycin which has activity as an antifungal agent and as an immunosuppressant.
Inventors
- 👤 John Ondeyka
- 👤 Otto Hensens
- 👤 Jerrold Liesch
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 02:21
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18; A; A61; A61P; A61P31/00; A61P31/04; A61P37/00; A61P37/02; A61P37/06
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
12 words
A compound of Formula I, ##STR5## or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
12 words
A compound of Formula I, ##STR5## or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
29 words
A pharmaceutical compositions for inducing immunosuppression in a subject in need of such treatment, comprising: a pharmaceutical carrier and a therapeutically effective amount of compound according to claim 1.
Claim 4
Dependent Claim
30 words
A method of inducing immunosuppression in a subject in need of such treatment, comprising administration to said subject a non toxic therapeutically effective amount of compound according to claim 1.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-02-24 | 1995-08-26 | 1996-02-25 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-02-24 | 1999-08-26 | 2000-02-25 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-02-24 | 2003-08-26 | 2004-02-25 | $7700.00 | Window Closed / Lapsed |